Literature DB >> 18436349

Molecular structure and stability of perindopril erbumine and perindopril L-arginine complexes.

Milan Remko1.   

Abstract

The methods of theoretical chemistry have been used to elucidate molecular properties of the antihypertensive, cardiovascular protective and antithrombotic perindopril ((2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid). The geometries and energies of various neutral and ionized complexes of perindopril erbumine and perindopril l-arginine have been computed using HF/6-31G(d) and Becke3LYP/6-31G(d) methods. The calculations showed that in both, the isolated state and water solution perindopril erbumine exists as a neutral complex. In the gas-phase perindopril l-arginine both neutral and ionic complexes are, at the HF level of theory, almost equally stable. The B3LYP level of theory slightly favors single proton transfer complex perindopril l-arginine (by about 14 kJ mol(-1)). In polar solvents like water, the ionized form of perindopril l-arginine becomes much more favored. According to our calculations l-arginine is bound to perindopril more strongly (by about 25 kJ mol(-1)) than erbumine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18436349     DOI: 10.1016/j.ejmech.2008.03.012

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Predicted environmental concentration and fate of the top 10 most dispensed Australian prescription pharmaceuticals.

Authors:  Timothy T X Ong; Ewan W Blanch; Oliver A H Jones
Journal:  Environ Sci Pollut Res Int       Date:  2018-02-04       Impact factor: 4.223

2.  Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite.

Authors:  Samer Hasan Hussein Al Ali; Mothanna Al-Qubaisi; Mohd Zobir Hussein; Maznah Ismail; Zulkarnain Zainal; Muhammad Nazrul Hakim
Journal:  Int J Nanomedicine       Date:  2012-04-24

3.  The Development and Validation of a Stability-Indicating UHPLC-DAD Method for Determination of Perindopril l-Arginine in Bulk Substance and Pharmaceutical Dosage Form.

Authors:  Magdalena Paczkowska; Przemysław Zalewski; Piotr Garbacki; Alicja Talaczyńska; Anna Krause; Judyta Cielecka-Piontek
Journal:  Chromatographia       Date:  2014-08-13       Impact factor: 2.044

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.